Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Financial Report: Patheon 3Q09 | Contract Pharma

What are you searching for?

Sign in
Breaking News, Financial News

Financial Report: Patheon 3Q09

Revenues dropped in both manufacturing and development services

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Patheon

3Q09 Revenues: $164.4 million (-16%)

3Q09 Loss: $6.0 million (loss of $14.0 million in 3Q08)

YTD Revenues: $479.0 million (-12%)

YTD Loss: $11.5 million (loss of $36.6 million YTD08)

Comments: Revenues were impacted by setbacks in operations in Puerto Rico, where the company “had difficulty releasing a sufficient volume of product lots due to efforts to optimize manufacturing parameters and difficulty meeting stringent release specifications for one product,” according to a Patheon statement. Overall, Commercial Manufacturing revenues dropped 16% to $132.9 million. The Pharma Development Services (PDS) unit saw a 17% increase in the number of projects underway in 3Q09, but revenues in that segment dropped 16% to $31.5 million. The company reported, “Unfortunately, the average value of these projects has declined due to a combination of increased price competition and pharmaceutical companies becoming more cautious with their development budgets. Patheon believes that this is a temporary, market driven situation, as sales of new business have recently shown a more encouraging trend.” For the year, manufacturing revenues have dropped 13% to $385.8 million and PDS revenues have fallen 9% to $93.2 million.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters